V. Bryan Lawlis, Director at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 7,500 shares at $74.47 ($559K) on 2019-09-17, disclosed to the SEC on 2019-09-18.
Open-market sale of $559k BMRN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.47 | 3,750 | $279K | 50.0% |
| 2 | $74.47 | 3,750 | $279K | 50.0% |
| Total | $74.47 avg | 7,500 | $559K | 100% |
| Filing → |
| GERN | SELL | 2023-05-11 | $105K | — | Filing → |
| BMRN | SELL | 2023-04-04 | $825K | — | Filing → |
| BMRN | SELL | 2022-04-18 | $356K | — | Filing → |